MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-17-0007004
Medispin Pharmaceutical Private Limited
Medispin Pharmaceutical Private Limited - pharma in Nashik, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.35 Cr
▲ 23% YoY
Net profit · FY 2024
₹23,506
Net margin 0.2%
EBITDA · FY 2024
₹7.09 Lakh
EBITDA margin 5.3%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹23 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Satisfied ₹24 Lakh
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Medispin Pharmaceutical Private Limited
Data last updated:
Medispin Pharmaceutical Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24234MH2011PTC223904. Its GSTIN is 27AAHCM5646C1ZH (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23 Lakh. It is led by directors Jaypalsingh Chandrasingh Jamadar and Chetan Ekanath Firake.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop C 113 1st Floor Roongta Central Park, Nashik, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.35 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹23,506 (net margin 0.2%) and EBITDA of ₹7.09 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹24 Lakh on record.
Medispin Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0007004). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24234MH2011PTC223904
Registration Number 223904
Incorporation Date 14 November 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-17-0007004
Recognitions & Rankings of Medispin Pharmaceutical
Contact details
Medispin Pharmaceutical Private Limited's registered office is in Nashik, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop C 113 1st Floor Roongta Central Park Apartment, Dwarka, Nashik, Maharashtra, India – 422001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medispin Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Medispin Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medispin Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medispin Pharmaceutical Private Limited, buy the company report.
Financials of Medispin Pharmaceutical Private Limited
FY 2024 filings availableMedispin Pharmaceutical Private Limited reported revenue of ₹1.35 Cr (up 23% YoY) for FY 2024.
Revenue · FY 2024
₹1.35 Cr ▲ 23%
Net profit · FY 2024
₹23,506 margin 0.2%
EBITDA · FY 2024
₹7.09 Lakh margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 2%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 16%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 23% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23,506 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medispin Pharmaceutical Private Limited, buy the company report.
Board of directors of Medispin Pharmaceutical Private Limited
Medispin Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaypalsingh Chandrasingh Jamadar Also directs: Bionordisk Laboratories LLP | Director | 14 Nov 2011 | 14 Years 11 Months | Current |
| Chetan Ekanath Firake | Director | 14 Nov 2011 | 14 Years 11 Months | Current |
Peer comparison
Medispin Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dowell Life Science Private Limited | ₹1.35 Cr (FY 2024) | 4.0% | Ahmedabad, Gujarat, India | |||
| Mkurizon Healthcare Private Limited | ₹1.35 Cr (FY 2024) | 30.0% | Bangalore, Karnataka, India | |||
| Medispin Pharmaceutical Private Limitedthis company | ₹1.35 Cr (FY 2024) | ₹23,506 | 0.2% | 23.0% | Nashik, Maharashtra, India | |
| Wellwish Pharma Private Limited | ₹1.34 Cr (FY 2024) | -9.0% | Nagpur, Maharashtra, India | |||
| Medisra Pharma Private Limited | ₹1.34 Cr (FY 2025) | 15.0% | Gurgaon, Haryana, India | |||
| Sarck Life Sciences Private Limited | ₹1.34 Cr (FY 2022) | 50.0% | Muzaffarpur, Bihar, India | |||
| Arakind Health Care Private Limited | ₹1.34 Cr (FY 2024) | 83.0% | Lko, Uttar Pradesh, India |
To see the full peer comparison of Medispin Pharmaceutical Private Limited, buy the company report.
Auditor
Medispin Pharmaceutical Private Limited is audited by PRASAD BHATT & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASAD BHATT & ASSOCIATES | FY 2023 | 123662W |
Shareholding
The shareholding of Medispin Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medispin Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
₹24 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jul 2022 | 100617509 | Bank of India | ₹50 Lakh | Open | |
| 18 Jan 2019 | 100235303 | Others | ₹24 Lakh | Satisfied |
To see the full charge records of Medispin Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Medispin Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medispin Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medispin Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM5646C1ZH | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medispin Pharmaceutical Private Limited, buy the company report.
Recent activity
Medispin Pharmaceutical Private Limited has 7 board changes on record since 2011: 2 appointments and 5 cessations. The latest: Changonda Sangonda Patil ceased to be Director on 11 Oct 2023.
AGM
Medispin Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Medispin Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Changonda Sangonda Patil ceased to be Director.
Ceased
Manisha Amol Morankar ceased to be Director.
Ceased
Nitin Sharad Patil ceased to be Director.
Ceased
Chandan Rajgopal Soni ceased to be Director.
Charges
A charge registered on 18 Jan 2019 via Charge ID 100235303 with Others was fully satisfied on 29 Jul 2022.
Charges
A charge with Bank Of India amounted to Rs. 50.00 Lakh with Charge ID 100617509 was registered on 11 Jul 2022.
Charges
A charge with Others of Rs. 24.00 Lakh registered on 18 Jan 2019 with Charge ID 100235303 was modified on 23 Jul 2020.
Ceased
Anita Prafulla Karpe ceased to be Director.
Charges
A charge with Others amounted to Rs. 24.00 Lakh with Charge ID 100235303 was registered on 18 Jan 2019.
Appointed
Chetan Ekanath Firake was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Medispin Pharmaceutical is an active private limited company based in Nashik, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 November 2011 (15+ years old) and is registered under CIN U24234MH2011PTC223904.
Medispin Pharmaceutical has 2 current directors:
- Jaypalsingh Chandrasingh Jamadar - Director
- Chetan Ekanath Firake - Director
The latest financial statements of Medispin Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Medispin Pharmaceutical is 27AAHCM5646C1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medispin Pharmaceutical is U24234MH2011PTC223904. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medispin Pharmaceutical was incorporated on 14 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medispin Pharmaceutical by revenue are Dowell Life Science Private Limited, Mkurizon Healthcare Private Limited, Wellwish Pharma Private Limited, Medisra Pharma Private Limited, Sarck Life Sciences Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Changonda Sangonda Patil ceased to be Director on 11 Oct 2023. Manisha Amol Morankar ceased to be Director on 11 Oct 2023. Nitin Sharad Patil ceased to be Director on 11 Oct 2023. Medispin Pharmaceutical has 7 board changes on record in total.
Yes, Medispin Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-17-0007004).
The registered office of Medispin Pharmaceutical is at Shop C 113 1st Floor Roongta Central Park Apartment, Dwarka, Nashik, Maharashtra, India – 422001.
Medispin Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.